226 related articles for article (PubMed ID: 26537645)
1. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
Ripping TM; Hubbard RA; Otten JD; den Heeten GJ; Verbeek AL; Broeders MJ
Int J Cancer; 2016 Apr; 138(7):1619-25. PubMed ID: 26537645
[TBL] [Abstract][Full Text] [Related]
2. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
3. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
4. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
[TBL] [Abstract][Full Text] [Related]
5. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.
Hubbard RA; Ripping TM; Chubak J; Broeders MJ; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):513-20. PubMed ID: 26721668
[TBL] [Abstract][Full Text] [Related]
6. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
[TBL] [Abstract][Full Text] [Related]
7. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
9. Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.
Román M; Quintana MJ; Ferrer J; Sala M; Castells X
Br J Cancer; 2017 May; 116(11):1480-1485. PubMed ID: 28427083
[TBL] [Abstract][Full Text] [Related]
10. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
[TBL] [Abstract][Full Text] [Related]
11. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
12. Risk of breast cancer after false-positive test results in screening mammography.
von Euler-Chelpin M; Risør LM; Thorsted BL; Vejborg I
J Natl Cancer Inst; 2012 May; 104(9):682-9. PubMed ID: 22491228
[TBL] [Abstract][Full Text] [Related]
13. Screening mammography in women less than age 50 years.
Kerlikowske K
Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
[TBL] [Abstract][Full Text] [Related]
14. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
Pace LE; Keating NL
JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
[TBL] [Abstract][Full Text] [Related]
15. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
16. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.
Singh D; Pitkäniemi J; Malila N; Anttila A
Breast Cancer Res Treat; 2016 Sep; 159(2):305-13. PubMed ID: 27496148
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer detection risk in screening mammography after a false-positive result.
Castells X; Román M; Romero A; Blanch J; Zubizarreta R; Ascunce N; Salas D; Burón A; Sala M;
Cancer Epidemiol; 2013 Feb; 37(1):85-90. PubMed ID: 23142338
[TBL] [Abstract][Full Text] [Related]
18. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
[TBL] [Abstract][Full Text] [Related]
19. Impact of extending screening mammography to older women: Information to support informed choices.
Jacklyn G; Howard K; Irwig L; Houssami N; Hersch J; Barratt A
Int J Cancer; 2017 Oct; 141(8):1540-1550. PubMed ID: 28662267
[TBL] [Abstract][Full Text] [Related]
20. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
